Ranbaxy Laboratories Limited

🇨🇷Costa Rica

Country: 🇨🇷Costa Rica

Ownership: -

Established: 1996-08-30

Employees: -

Market Cap: -

Website

Clinical Trials

Bioequivalence Study of Amlodipine Tablets Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: amlodipine 10 mg tablet

First Posted Date: 2008-10-20

Last Posted Date: 2008-10-20

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 40

Registration Number: NCT00775905

Locations: 🇺🇸
SFBC Ft. Myers, Inc., Fort Myers,, Florida, United States

Bioequivalence Study of Atenolol 100mg Tablets Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Atenolol 100mg Tablets

First Posted Date: 2008-10-20

Last Posted Date: 2008-10-20

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 36

Registration Number: NCT00775580

Locations: 🇺🇸
aaiPharma, Inc. -AAI Clinic, Chapell Hill, North Carolina, United States

Bioequivalency Study of Fenofibrate 160mg Tablets Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: fenofibrate 160 mg tablets

First Posted Date: 2008-10-20

Last Posted Date: 2008-10-20

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 40

Registration Number: NCT00775827

Locations: 🇮🇳
Ranbaxy Research Laboratories, Gurgaon, Haryana, India

Bioequivalence Study of Clarithromycin 250 mg/5 mL Powder for Oral Suspension Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: clarithromycin 250 mg/5 mL powder for oral suspension

First Posted Date: 2008-10-20

Last Posted Date: 2008-10-20

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 40

Registration Number: NCT00775255

Bioequivalence Study of Amlodipine 10mg Tablets Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: amlodipine 10 mg tablet

First Posted Date: 2008-10-20

Last Posted Date: 2008-10-20

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 40

Registration Number: NCT00775151

Locations: 🇺🇸
SFBC Ft. Myers, Inc., Fort Myers, Florida, United States

Bioequivalence Study of Doxycycline Monohydrate 100mg Tablets Under Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Doxycycline monohydrate 100mg tablets

First Posted Date: 2008-10-20

Last Posted Date: 2008-10-20

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 32

Registration Number: NCT00775177

Locations: 🇺🇸
aaiPharma, Inc, Chapel Hill, North Carolina, United States

Bioequivaelnce Study of Doxycycline Monohydrate 100mg Tablets Under Fed Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Doxycycline monohydrate 100mg tablets

First Posted Date: 2008-10-20

Last Posted Date: 2008-10-20

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 32

Registration Number: NCT00775918

Locations: 🇺🇸
aaiPharma, Inc., Chapel Hill, North Carolina, United States

Bioequivalence Study of Clarithromycin 500mg Tablets Under Fasting Conditions.

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: Clarithromycin 500mg

First Posted Date: 2008-10-17

Last Posted Date: 2008-11-18

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 33

Registration Number: NCT00774644

Locations: 🇺🇸
Gateway Medical Research Inc., St.Charles, Missouri, United States

Bioequivalence Study of Clarithromycin 250mg Tablets Under Fasting Conditions

Phase 1

Completed

Conditions: Healthy

Interventions: Drug: clarithromycin 250 mg tablets

First Posted Date: 2008-10-17

Last Posted Date: 2008-10-17

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 32

Registration Number: NCT00774189

Locations: 🇮🇳
Ranbaxy Research Laboratories, Gurgaon, Haryana, India

Bioequivalence Study of Clarithromycin 500 mg Tablets Under Non-Fasting Conditions

Not Applicable

Completed

Conditions: Healthy

Interventions: Drug: clarithromycin 500mg tablets

First Posted Date: 2008-10-17

Last Posted Date: 2008-10-17

Lead Sponsor: Ranbaxy Laboratories Limited

Target Recruit Count: 24

Registration Number: NCT00774696

Locations: 🇺🇸
Gateway Medical Research Inc., St.Charles, Missouri, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy